Myths and facts on adjuvant carboplatin for stage I seminoma

J Clin Oncol. 2006 Jul 20;24(21):e40. doi: 10.1200/JCO.2006.05.7802.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carboplatin / administration & dosage
  • Carboplatin / adverse effects
  • Carboplatin / therapeutic use*
  • Chemotherapy, Adjuvant
  • Clinical Trials as Topic
  • Drug Administration Schedule
  • Humans
  • Male
  • Multicenter Studies as Topic
  • Neoplasm Staging
  • Neoplasms, Second Primary / etiology*
  • Orchiectomy
  • Radiotherapy, Adjuvant / adverse effects
  • Retroperitoneal Neoplasms / drug therapy
  • Retroperitoneal Neoplasms / prevention & control
  • Retroperitoneal Neoplasms / secondary
  • Risk Assessment
  • Salvage Therapy
  • Seminoma / drug therapy*
  • Seminoma / pathology
  • Seminoma / surgery
  • Testicular Neoplasms / drug therapy*
  • Testicular Neoplasms / pathology
  • Testicular Neoplasms / surgery
  • Treatment Outcome

Substances

  • Carboplatin